Leuko Labs, Inc.

Cambridge, MA

UEI
T7SWKPALXK88
CAGE
7X9C2
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Hispanic American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
678 Massachusetts Ave #301, Cambridge, MA 02139, USA
Website
leuko.com
Founded
2017
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Reducing the incidence of febrile neutropenia in cancer patients treated with chemotherapy with pointcheck: a… R44CA228920 National Cancer Institute (NIH) $9,800,642
Reducing the incidence of febrile neutropenia in cancer patients treated with chemotherapy with pointcheck: a… R43CA228920 National Cancer Institute (NIH) $268,919

Quick answers

Is Leuko Labs, Inc. registered in SAM.gov?

Yes. Leuko Labs, Inc.'s SAM.gov registration is active through January 21, 2027.

What is Leuko Labs, Inc.'s most recent federal award?

Leuko Labs, Inc.'s most recent federal grant award is Reducing the incidence of febrile neutropenia in cancer patients treated with chemotherapy with pointcheck: a… (R44CA228920), from National Cancer Institute (NIH), on July 12, 2018.

On GovTribe

See Leuko Labs, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login